GLP-1 and Hormone Therapy for Weight Loss

Name: GLP-1 and Hormone Therapy for Weight Loss
Uploaded: 2025-01-07T13:00:29+00:00
Duration: 49 s
Channel: Dr. Charles Mok
Description: A short clinician-led YouTube talk (Dr. Charles Mok) comparing GLP-1 receptor agonists (examples: semaglutide, tirzepatide; brands: Wegovy, Ozempic…

7 Jan 2025 · 1 min

Watch on YouTube

0:49

A short clinician-led YouTube talk (Dr. Charles Mok) comparing GLP-1 receptor agonists (examples: semaglutide, tirzepatide; brands: Wegovy, Ozempic, Zepbound) and hormone replacement therapy for weight loss. The speaker emphasizes these are not mutually exclusive, often synergistic, and that optimal choice depends on whether weight issues stem primarily from hormone derangement or from metabolic dysfunction/metabolic syndrome. The speaker signals a forthcoming review of which hormone imbalances cause weight gain and how hormone therapy can help.

Chapters

Common question I get is, you know, I want to lose weight, and should I do hormone replacement therapy or these GLP1 agonists such as semaglutide or tirzepatide, also known as Wegovy, Ozempic, zepbound in Mongerno? That's a great question. And it's really probably not a one or the other. If you have hormone derangement, you can lose weight on these drugs on the GLP1 agonist, but you're really fighting potentially the wrong battle. And if you go on hormone replacement therapy and you have metabolic dysfunction, obesity syndrome X or metabolic syndrome, probably you're gonna get some benefit. Clinically, I can get some benefit with weight, but still maybe missing. Okay, key component. I'll tell you that they are synergistic. So let's just go over this briefly. What hormone dysregulation can cause weight gain and how can hormones improve it.